Regenerative treatment using a radioelectric asymmetric conveyor as a novel tool in antiaging medicine: an in vitro beta-galactosidase study | Zendy

Salvatore Rinaldi | Zendy; Vania Fontani | Zendy; Alessandro Castagna | Zendy; Margotti Lotti | Zendy; Ventura | Zendy; Margherita Maioli | Zendy; Santaniello | Zendy; Pigliaru | Zendy; Arturo Carta | Zendy; Gualini | Zendy

Open Access

Regenerative treatment using a radioelectric asymmetric conveyor as a novel tool in antiaging medicine: an in vitro beta-galactosidase study

Author(s) -

Salvatore Rinaldi,

Vania Fontani,

Alessandro Castagna,

Margotti Lotti,

Ventura,

Margherita Maioli,

Santaniello,

Pigliaru,

Arturo Carta,

Gualini

Publication year - 2012

Publication title -

clinical interventions in aging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.184

H-Index - 76

eISSN - 1178-1998

pISSN - 1176-9092

DOI - 10.2147/cia.s33312

Subject(s) - adipose tissue , stem cell , in vitro , medicine , senescence , microbiology and biotechnology , neurodegeneration , cellular senescence , biomarker , pathology , biology , phenotype , biochemistry , disease , gene

Beta-galactosidase is the most widely used biomarker for highlighting the processes of cellular aging, including neurodegeneration. On this basis, we decided to test in vitro whether a set of rescuing/reparative events previously observed by us in subjects treated with radioelectric asymmetric conveyor (REAC) technology may also involve antagonism of a marker of aging-related degenerative processes, as assessed by a reduction in beta-galactosidase at the cellular level.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research